Patent 7879796 was granted and assigned to Abbott on February, 2011 by the United States Patent and Trademark Office.
Disclosed are compositions, including low-calorie beverages or liquids, comprising isoleucine, leucine, valine, cysteine, and methionine, in specified amounts, weight ratios, or both. The compositions are especially useful in treating individuals afflicted with impaired glucose tolerance or diabetes.